Catalyst Wire Dossier Catalyst Wire Dossier

Lobeline

lobeline · Yaupon Therapeutics
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Lobeline, covering 2013-06-20 to 2017-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 [Phase 1]

See pricing